Clinical Trials Logo

Clinical Trial Summary

This study is being done to determine whether measures of brain activity (known as cortical excitability and inhibition) collected by Transcranial Magnetic Stimulation (TMS) are different in children and adolescents with depression and children and adolescents that do not have depression.


Clinical Trial Description

The purpose of this study is determine whether single and paired-pulse transcranial magnetic stimulation (TMS) can be used to detect brain changes in children and adolescents with major depressive disorder. Transcranial magnetic stimulation is a noninvasive focal brain stimulation technology which makes certain parts of the brain work without putting any wires or chemicals into the body. Single and paired-pulse TMS involves giving one or two brief magnetic pulses to the brain no more often than every few seconds and measuring the subject's thumb movements. This is different from what is called repetitive transcranial magnetic stimulation (rTMS) in which investigators rapidly give many pulses to the brain with the idea of altering brain function and treating illnesses. This study does not involve any treatment. It is a study to examine the brain changes associated with depression in children and adolescents. The techniques which will be used in this study (single and paired-pulse TMS) are much safer than rTMS and have been used safely and frequently (over 2,000 published cases) for research in children.

Investigators in this study will use TMS to measure cortical excitability (how active the brain is) and cortical inhibition (how active the brain is and how well chemicals which slow brain functions are working) in children and adolescents with MDD and healthy controls. The aims of this study are to compare these measures of cortical excitability and inhibition in these two groups (depressed children and adolescents and normal controls), and to determine if there is a relationship between these measures of cortical inhibition and excitability and how severe symptoms of depression are in subjects and if these measures change differently with age in depressed children and adolescents and normal controls. The investigators hypothesize that subjects with depression will have decreased cortical inhibition compared to healthy controls and that depressed subjects will have greater differences in cortical inhibition on the left and right sides of their brains than healthy controls. The investigators also hypothesize that subjects with more severe symptoms of depression will have lower cortical inhibition. Also it is hypothesized that, in depressed subjects, cortical inhibition will not increase with age as significantly as it does in healthy controls. ;


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT00896090
Study type Observational
Source University of Texas Southwestern Medical Center
Contact Paul Croarkin, D.O.
Phone 214-456-4224
Email paul.croarkin@utsouthwestern.edu
Status Recruiting
Phase Phase 1
Start date April 2009
Completion date December 2011

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A